Kai-Uwe Eckardt

Professor / Director

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Kai-Uwe Eckardt is the Director at Charité Universitätsmedizin Berlin, Germany. His research focuses on chronic kidney disease (CKD), kidney transplantation, and related metabolic disorders, as evidenced by his recent articles exploring topics such as CKD-related anemia, gut dysbiosis, and long-term outcomes in patients with IgA nephropathy and FSGS. His work aims to advance understanding and treatment of kidney-related health challenges.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Felix Behrens

Charité - Universitätsmedizin Berlin

GERMANY

Kai-Uwe Eckardt

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Valosin-containing protein in ciliary morphology: a novel target in ADPKD.

Safety and Efficacy of Vadadustat for the Treatment of CKD-Related Anemia within and outside the United States

Anemia and iron deficiency in post-kidney transplantation: an unsolved challenge

CAKUT subtypes determine the rate of progression to kidney failure – an adult patient cohort study

Gut dysbiosis contributes to TMAO accumulation in CKD

Long-term outcomes of patients with IgA nephropathy in the German CKD cohort

Continuous glucose monitoring for the prediction of posttransplant diabetes mellitus and impaired glucose tolerance on day 90 after kidney transplantation—A prospective proof-of-concept study

Pre-emptive use of glucose 5% as the standard drug solvent reduces hypernatremia in critically ill patients

Serum and Urine Metabolites and Kidney Function

Long-term outcomes of adults with FSGS in the German Chronic Kidney Disease cohort

SLC26A1 is a major determinant of sulfate homeostasis in humans.

Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis

Armed conflicts and kidney patients: a consensus statement from the Renal Disaster Relief Task Force of the ERA

Uromodulin and its association with urinary metabolites: the German Chronic Kidney Disease Study

PCSK9 and Cardiovascular Disease in Individuals with Moderately Decreased Kidney Function

Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.

Protective α1-antitrypsin effects in autoimmune vasculitis are compromised by methionine oxidation

Mitochondrial DNA and Kidney Function

Successful control of Candida auris transmission in a German COVID‐19 intensive care unit

Evaluation of severity of delayed graft function in kidney transplant recipients

Collaborators (16)

Felix Behrens

Ralph Kettritz

Andrzej Więcek

Eleni Stamellou

Ulla T Schultheiss

Johannes Holle

Harithaa Anandakumar

D. D. Ivanov

Felix Knauf

Ewa Pawlowicz

Michael Becker

Katharina Ziegeler

Wendy McCallum

Jan Halbritter

Alexander Maximilian Aldejohann

Adrian Schreiber

Make your next move.